Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Chi-Tung Cheng, Yin-Yi Chu, Chun-Nan Yeh, Shih-Chiang Huang, Ming Huang Chen, Shang-Yu Wang, Chun-Yi Tsai, Kun-Chun Chiang, Yen-Yang Chen, Ming-Chun Ma, Chien-Ting Liu, Tsung-Wen Chen & Ta-Sen Yeh. (2015) Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma. OncoTargets and Therapy 8, pages 1899-1907.
Read now
Read now
Chinmay Gundewar, Agata Sasor, Katarzyna Said Hilmersson, Roland Andersson & Daniel Ansari. (2015) The role of SPARC expression in pancreatic cancer progression and patient survival. Scandinavian Journal of Gastroenterology 50:9, pages 1170-1174.
Read now
Read now
Albrecht Neesse, Sebastian Krug, Thomas M Gress, David A Tuveson & Patrick Michl. (2014) Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma. OncoTargets and Therapy 7, pages 33-43.
Read now
Read now
Elisa Fontana, Francesco Sclafani & David Cunningham. (2014) Emerging treatments for advanced pancreatic cancer: clinical potential of albumin-bound paclitaxel. Gastrointestinal Cancer: Targets and Therapy 4, pages 89-101.
Read now
Read now
Edna Cukierman & Daniel E. Bassi. (2012) The mesenchymal tumor microenvironment. Cell Adhesion & Migration 6:3, pages 285-296.
Read now
Read now
Evgeniya Petrova, Davide Soldini & Eduardo Moreno. (2011) The expression of SPARC in human tumors is consistent with its role during cell competition. Communicative & Integrative Biology 4:2, pages 171-174.
Read now
Read now
Rebecca A Moss & Clifton Lee. (2010) Current and emerging therapies for the treatment of pancreatic cancer. OncoTargets and Therapy 3, pages 111-127.
Read now
Read now
Anne M. Delany. (2010) Matricellular proteins osteopontin and osteonectin/SPARC in pancreatic carcinoma. Cancer Biology & Therapy 10:1, pages 65-67.
Read now
Read now
Articles from other publishers (75)
Sujit Suklabaidya, Biswajit Das, Syed Azmal Ali, Sumeet Jain, Sharada Swaminathan, Ashok K. Mohanty, Susen K. Panda, Pujarini Dash, Subhankar Chakraborty, Surinder K. Batra & Shantibhusan Senapati. (2016) Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia. Oncotarget 7:27, pages 41825-41842.
Crossref
Crossref
Md Sazzad Hassan, Niranjan Awasthi, Saisantosh Ponna & Urs von Holzen. (2023) Nab-Paclitaxel in the Treatment of Gastrointestinal Cancers—Improvements in Clinical Efficacy and Safety. Biomedicines 11:7, pages 2000.
Crossref
Crossref
Shuai Shi, Hong-Yan Ma, Xin-Ying Han, Yin-Zhou Sang, Ming-Yue Yang & Zhi-Gang Zhang. (2022) Prognostic Significance of SPARC Expression in Breast Cancer: A Meta-Analysis and Bioinformatics Analysis. BioMed Research International 2022, pages 1-11.
Crossref
Crossref
Etienne J. Slapak, Mouad el Mandili, Maarten F. Bijlsma & C. Arnold Spek. (2022) Mesoporous Silica Nanoparticle-Based Drug Delivery Systems for the Treatment of Pancreatic Cancer: A Systematic Literature Overview. Pharmaceutics 14:2, pages 390.
Crossref
Crossref
Xiaoting Sun, Xingkang He, Yin Zhang, Kayoko Hosaka, Patrik Andersson, Jing Wu, Jieyu Wu, Xu Jing, Qiqiao Du, Xiaoli Hui, Bo Ding, Ziheng Guo, An Hong, Xuan Liu, Yan Wang, Qing Ji, Rudi Beyaert, Yunlong Yang, Qi Li & Yihai Cao. (2022) Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. Gut 71:1, pages 129-147.
Crossref
Crossref
Sachiko Yoshida, Kazuo Asanoma, Hiroshi Yagi, Ichiro Onoyama, Emiko Hori, Yumiko Matsumura, Kaoru Okugawa, Hideaki Yahata & Kiyoko Kato. (2021) Fibronectin mediates activation of stromal fibroblasts by SPARC in endometrial cancer cells. BMC Cancer 21:1.
Crossref
Crossref
Linh-Huyen Truong & Siim Pauklin. (2021) Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches. Cancers 13:19, pages 5028.
Crossref
Crossref
Etienne J. Slapak, Lily Kong, Mouad el Mandili, Rienk Nieuwland, Alexander Kros, Maarten F. Bijlsma & C. Arnold Spek. (2021) ADAM9-Responsive Mesoporous Silica Nanoparticles for Targeted Drug Delivery in Pancreatic Cancer. Cancers 13:13, pages 3321.
Crossref
Crossref
Tatsuya Suwa, Minoru Kobayashi, Jin-Min Nam & Hiroshi Harada. (2021) Tumor microenvironment and radioresistance. Experimental & Molecular Medicine 53:6, pages 1029-1035.
Crossref
Crossref
Rami Alzhrani, Hashem O. Alsaab, Kushal Vanamala, Ketki Bhise, Katyayani Tatiparti, Ayatakshi Barari, Samaresh Sau & Arun K. Iyer. (2021) Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes. Advanced Therapeutics 4:6, pages 2000262.
Crossref
Crossref
Manoj Amrutkar & Ivar P. Gladhaug. (2021) Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer. Cancers 13:4, pages 601.
Crossref
Crossref
Elisabeth HessmannSoeren M. BuchholzIhsan Ekin DemirShiv K. SinghThomas M. GressVolker EllenriederAlbrecht Neesse. (2020) Microenvironmental Determinants of Pancreatic Cancer. Physiological Reviews 100:4, pages 1707-1751.
Crossref
Crossref
Christopher Hartley, Daniel Rowan, Xiuxu Chen, Luisa Gomez-Arellano, Anna Marie West, Kiyoko Oshima & Alexander Craig Mackinnon. (2020) Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma. Practical Laboratory Medicine 21, pages e00171.
Crossref
Crossref
Jiali Du, Jichun Gu & Ji Li. (2020) Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels. Bioscience Reports 40:7.
Crossref
Crossref
Mingtian Che, Soo-Mi Kweon, Jia-Ling Teo, Yate-Ching Yuan, Laleh G. Melstrom, Richard T. Waldron, Aurelia Lugea, Raul A. Urrutia, Stephen J. Pandol & Keane K. Y. Lai. (2020) Targeting the CBP/β-Catenin Interaction to Suppress Activation of Cancer-Promoting Pancreatic Stellate Cells. Cancers 12:6, pages 1476.
Crossref
Crossref
Tianqi Su, Bo Yang, Tianren Gao, Tongjun Liu & Jiannan Li. (2020) Polymer nanoparticle-assisted chemotherapy of pancreatic cancer. Therapeutic Advances in Medical Oncology 12, pages 175883592091597.
Crossref
Crossref
Denise Camacho, Joana P. Jesus, António M. Palma, Sofia A. Martins, Alexandre Afonso, Maria Leonor Peixoto, Christopher J. Pelham, Eduardo Moreno & Rajan Gogna. 2020.
171
199
.
Fabio Grizzi, Sirio Fiorino, Dorina Qehajaj, Adele Fornelli, Carlo Russo, Dario de Biase, Michele Masetti, Laura Mastrangelo, Matteo Zanello, Raffaele Lombardi, Andrea Domanico, Esterita Accogli, Andrea Tura, Leonardo Mirandola, Maurizio Chiriva-Internati, Robert S. Bresalier, Elio Jovine, Paolo Leandri & Luca Di Tommaso. (2019) Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study. Journal of Translational Medicine 17:1.
Crossref
Crossref
Khusbu Khetan, Vandana Baloda, Ranjit K. Sahoo, Sreenivas Vishnubhathla, Rajni Yadav, Anoop Saraya, Atul Sharma, Siddhartha Datta Gupta & Prasenjit Das. (2019) SPARC expression in desmoplastic and non desmoplastic pancreatic carcinoma and cholangiocarcinoma. Pathology - Research and Practice 215:12, pages 152685.
Crossref
Crossref
Norihiro Ishii, Kenichiro Araki, Takehiko Yokobori, Kei Hagiwara, Dorgormaa Gantumur, Takahiro Yamanaka, Tadashi Handa, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Norifumi Harimoto, Atsushi Masamune, Kazuo Umezawa, Hiroyuki Kuwano & Ken Shirabe. (2018) Conophylline suppresses pancreatic cancer desmoplasia and cancer‐promoting cytokines produced by cancer‐associated fibroblasts. Cancer Science 110:1, pages 334-344.
Crossref
Crossref
Ozkan Kanat & Hulya Ertas. (2018) Shattering the castle walls: Anti-stromal therapy for pancreatic cancer. World Journal of Gastrointestinal Oncology 10:8, pages 202-210.
Crossref
Crossref
Ryuta Shintakuya, Naru Kondo, Yoshiaki Murakami, Kenichiro Uemura, Naoya Nakagawa, Keisuke Okano, Shinya Takahashi & Taijiro Sueda. (2018) The high stromal SPARC expression is independently associated with poor survival of patients with resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine in combination with S-1 or adjuvant gemcitabine alone. Pancreatology 18:2, pages 191-197.
Crossref
Crossref
Chen Liang, Si Shi, Qingcai Meng, Dingkong Liang, Shunrong Ji, Bo Zhang, Yi Qin, Jin Xu, Quanxing Ni & Xianjun Yu. (2017) Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?. Cellular and Molecular Life Sciences 75:6, pages 1001-1012.
Crossref
Crossref
Hironori Aoki, Eiichiro Yamamoto, Akira Takasawa, Takeshi Niinuma, Hiro-O Yamano, Taku Harada, Hiro-O Matsushita, Kenjiro Yoshikawa, Ryo Takagi, Eiji Harada, Yoshihito Tanaka, Yuko Yoshida, Tomoyuki Aoyama, Makoto Eizuka, Akira Yorozu, Hiroshi Kitajima, Masahiro Kai, Norimasa Sawada, Tamotsu Sugai, Hiroshi Nakase & Hiromu Suzuki. (2017)
Epigenetic silencing of
SMOC1
in traditional serrated adenoma and colorectal cancer
. Oncotarget 9:4, pages 4707-4721.
Crossref
Crossref
Maria Diab & Philip A. Philip. 2018. Current and Emerging Therapies in Pancreatic Cancer. Current and Emerging Therapies in Pancreatic Cancer
119
134
.
Masao Nakajima, Shigefumi Yoshino, Shinsuke Kanekiyo, Noriko Maeda, Kazuhiko Sakamoto, Ryoichi Tsunedomi, Nobuaki Suzuki, Shigeru Takeda, Shigeru Yamamoto, Shoichi Hazama, Yoshinobu Hoshii, Atsunori Oga, Hiroshi Itoh, Tomio Ueno & Hiroaki Nagano. (2017) High secreted protein acidic and rich in cysteine expression in peritumoral fibroblasts predicts better prognosis in patients with resectable gastric cancer. Oncology Letters.
Crossref
Crossref
Hyunjin Park, Yangkyu Lee, Hyejung Lee, Jin-Won Kim, Jin-Hyeok Hwang, Jaihwan Kim, Yoo-Seok Yoon, Ho-Seong Han & Haeryoung Kim. (2017) The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Tumor Biology 39:10, pages 101042831771840.
Crossref
Crossref
Cristina Arqueros, Juliana Salazar, M. J. Arranz, Ana Sebio, Josefina Mora, Ivana Sullivan, María Tobeña, Marta Martín-Richard, Agustí Barnadas, Montserrat Baiget & David Páez. (2017) SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients. Medical Oncology 34:8.
Crossref
Crossref
Laleh G. Melstrom, Marcela D. Salazar & Don J. Diamond. (2017) The pancreatic cancer microenvironment: A true double agent. Journal of Surgical Oncology 116:1, pages 7-15.
Crossref
Crossref
Xin-Zhe Yu, Zhong-Yi Guo, Yang Di, Feng Yang, Qi Ouyang, De-Liang Fu & Chen Jin. (2017) The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival. Hepatobiliary & Pancreatic Diseases International 16:1, pages 104-109.
Crossref
Crossref
Katrina Viloria, Amanda Munasinghe, Sharan Asher, Roberto Bogyere, Lucy Jones & Natasha J. Hill. (2016) A holistic approach to dissecting SPARC family protein complexity reveals FSTL-1 as an inhibitor of pancreatic cancer cell growth. Scientific Reports 6:1.
Crossref
Crossref
Steffen Ormanns, Michael Haas, Sibylle Baechmann, Annelore Altendorf-Hofmann, Anna Remold, Detlef Quietzsch, Michael R Clemens, Martin Bentz, Michael Geissler, Helmut Lambertz, Stephan Kruger, Thomas Kirchner, Volker Heinemann & Stefan Boeck. (2016) Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials. British Journal of Cancer 115:12, pages 1520-1529.
Crossref
Crossref
Srinivasa P. Pothula, Zhihong Xu, David Goldstein, Romano C. Pirola, Jeremy S. Wilson & Minoti V. Apte. (2016) Key role of pancreatic stellate cells in pancreatic cancer. Cancer Letters 381:1, pages 194-200.
Crossref
Crossref
Monica Rossi, Manu Gnanamony & Christopher Gondi. (2016) The ‘SPARC’ of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review). International Journal of Oncology.
Crossref
Crossref
Wei Han, Fang Cao, Min-bin Chen, Rong-zhu Lu, Hua-bing Wang, Min Yu, Chun-tao Shi & Hou-zhong Ding. (2016) Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis. PLOS ONE 11:1, pages e0145803.
Crossref
Crossref
Michael Friberg Bruun Nielsen, Michael Bau Mortensen & Sönke Detlefsen. (2016) Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells. World Journal of Gastroenterology 22:9, pages 2678.
Crossref
Crossref
Archana Bhaw-Luximon & Dhanjay Jhurry. (2015) New avenues for improving pancreatic ductal adenocarcinoma (PDAC) treatment: Selective stroma depletion combined with nano drug delivery. Cancer Letters 369:2, pages 266-273.
Crossref
Crossref
Hai Hu, Feng Jiao, Ting Han & Li-Wei Wang. (2015) Functional significance of macrophages in pancreatic cancer biology. Tumor Biology 36:12, pages 9119-9126.
Crossref
Crossref
Rajan Gogna, Kevin Shee & Eduardo Moreno. (2015) Cell Competition During Growth and Regeneration. Annual Review of Genetics 49:1, pages 697-718.
Crossref
Crossref
Nigel B. Jamieson, David K. Chang & Andrew V. Biankin. (2015) Cancer Genetics and Implications for Clinical Management. Surgical Clinics of North America 95:5, pages 919-934.
Crossref
Crossref
Stephanie E. Combs. (2015) Individualized radiotherapy (iRT) concepts for locally advanced pancreatic cancer (LAPC): indications and prognostic factors. Langenbeck's Archives of Surgery 400:7, pages 749-756.
Crossref
Crossref
J.S. Graham, N.B. Jamieson, R. Rulach, S.M. Grimmond, D.K. Chang & A.V. Biankin. (2015) Pancreatic cancer genomics: where can the science take us?. Clinical Genetics 88:3, pages 213-219.
Crossref
Crossref
Francesco Sclafani, Ridhima Iyer, David Cunningham & Naureen Starling. (2015) Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets. Critical Reviews in Oncology/Hematology 95:3, pages 318-336.
Crossref
Crossref
Atsushi Masamune & Tooru Shimosegawa. (2015) Pancreatic stellate cells: A dynamic player of the intercellular communication in pancreatic cancer. Clinics and Research in Hepatology and Gastroenterology 39, pages S98-S103.
Crossref
Crossref
Tomohiro Yamada, Seiji Ohno, Naoya Kitamura, Eri Sasabe & Tetsuya Yamamoto. (2014) SPARC is associated with carcinogenesis of oral squamous epithelium and consistent with cell competition. Medical Molecular Morphology 48:3, pages 129-137.
Crossref
Crossref
Emmanouil Fokas, Eric O'Neill, Alex Gordon-Weeks, Somnath Mukherjee, W. Gillies McKenna & Ruth J. Muschel. (2015) Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1855:1, pages 61-82.
Crossref
Crossref
Shinsuke Nakashima, Shogo Kobayashi, Daisuke Sakai, Akira Tomokuni, Yoshito Tomimaru, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, Shigeru Marubashi, Hidetoshi Eguchi, Nariaki Matsuura, Yuichiro Doki, Masaki Mori & Hiroaki Nagano. (2014) Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer. Journal of Surgical Oncology 110:8, pages 1016-1022.
Crossref
Crossref
Albrecht Neesse, Kristopher K Frese, Derek S Chan, Tashinga E Bapiro, William J Howat, Frances M Richards, Volker Ellenrieder, Duncan I Jodrell & David A Tuveson. (2014)
SPARC independent drug delivery and antitumour effects of
nab
-paclitaxel in genetically engineered mice
. Gut 63:6, pages 974-983.
Crossref
Crossref
M. Sinn, B.V. Sinn, J.K. Striefler, J.L. Lindner, J.M. Stieler, P. Lohneis, S. Bischoff, H. Bläker, U. Pelzer, M. Bahra, M. Dietel, B. Dörken, H. Oettle, H. Riess & C. Denkert. (2014) SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study. Annals of Oncology 25:5, pages 1025-1032.
Crossref
Crossref
Shin Hamada, Atsushi Masamune & Tooru Shimosegawa. (2013) Inflammation and pancreatic cancer: disease promoter and new therapeutic target. Journal of Gastroenterology 49:4, pages 605-617.
Crossref
Crossref
V. Heinemann, M. Reni, M. Ychou, D.J. Richel, T. Macarulla & M. Ducreux. (2014) Tumour?stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies. Cancer Treatment Reviews 40:1, pages 118-128.
Crossref
Crossref
Serena Lunardi, Ruth J. Muschel & Thomas B. Brunner. (2014) The stromal compartments in pancreatic cancer: Are there any therapeutic targets?. Cancer Letters 343:2, pages 147-155.
Crossref
Crossref
Ferda Kaleağasıoğlu. (2014) SIBLINGs and SPARC families: Their emerging roles in pancreatic cancer. World Journal of Gastroenterology 20:40, pages 14747.
Crossref
Crossref
David K. Chang, Nigel B. Jamieson, Sean M. Grimmond & Andrew V. Biankin. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine
807
814
.
Cindy Neuzillet, Annemilaï Tijeras-Raballand, Jérôme Cros, Sandrine Faivre, Pascal Hammel & Eric Raymond. (2013) Stromal expression of SPARC in pancreatic adenocarcinoma. Cancer and Metastasis Reviews 32:3-4, pages 585-602.
Crossref
Crossref
Alyssa Charrier & David R. Brigstock. (2013) Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2). Cytokine & Growth Factor Reviews 24:1, pages 59-68.
Crossref
Crossref
Hai-Yun Wang, Yang-Yang Li, Qiong Shao, Jing-Hui Hou, Fang Wang, Man-Bo Cai, Yi-Xin Zeng & Jian-Yong Shao. (2012) Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis. Journal of Translational Medicine 10:1.
Crossref
Crossref
Xiangyu Kong, Lei Li, Zhaoshen Li & Keping Xie. (2012) Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: Molecular basis for therapeutic implications. Cytokine & Growth Factor Reviews 23:6, pages 343-356.
Crossref
Crossref
Zhi Ven Fong & Jordan M. Winter. (2012) Biomarkers in Pancreatic Cancer. The Cancer Journal 18:6, pages 530-538.
Crossref
Crossref
Oliver G. McDonald, Anirban Maitra & Ralph H. Hruban. (2012) Human Correlates of Provocative Questions in Pancreatic Pathology. Advances in Anatomic Pathology 19:6, pages 351-362.
Crossref
Crossref
Christine Feig, Aarthi Gopinathan, Albrecht Neesse, Derek S. Chan, Natalie Cook & David A. Tuveson. (2012) The Pancreas Cancer Microenvironment. Clinical Cancer Research 18:16, pages 4266-4276.
Crossref
Crossref
Gerald P. Guntle, Bhumasamudram Jagadish, Eugene A. Mash, Garth Powis, Robert T. Dorr & Natarajan Raghunand. (2012) Tumor Xenograft Response to Redox-Active Therapies Assessed by Magnetic Resonance Imaging Using a Thiol-Bearing DOTA Complex of Gadolinium. Translational Oncology 5:3, pages 190-199.
Crossref
Crossref
M A Lowery & E M O'Reilly. (2011) Genomics and pharmacogenomics of pancreatic adenocarcinoma. The Pharmacogenomics Journal 12:1, pages 1-9.
Crossref
Crossref
Angela L. McCleary-Wheeler, Robert McWilliams & Martin E. Fernandez-Zapico. (2012) Aberrant signaling pathways in pancreatic cancer: A two compartment view. Molecular Carcinogenesis 51:1, pages 25-39.
Crossref
Crossref
Tine S. Mantoni, Serena Lunardi, Osama Al-Assar, Atsushi Masamune & Thomas B. Brunner. (2011) Pancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells through β1-Integrin Signaling. Cancer Research 71:10, pages 3453-3458.
Crossref
Crossref
Siri Dunér, Jacob Lopatko Lindman, Daniel Ansari, Chinmay Gundewar & Roland Andersson. (2011) Pancreatic Cancer: The Role of Pancreatic Stellate Cells in Tumor Progression. Pancreatology 10:6, pages 673-681.
Crossref
Crossref
Konstantinos Karapanos & Iakovos N. Nomikos. (2011) Current Surgical Aspects of Palliative Treatment for Unresectable Pancreatic Cancer. Cancers 3:1, pages 636-651.
Crossref
Crossref
Hayato Fujita, Kenoki Ohuchida, Kazuhiro Mizumoto, Kohei Nakata, Jun Yu, Tadashi Kayashima, Lin Cui, Tatsuya Manabe, Takao Ohtsuka & Masao Tanaka. (2010) α-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal Adenocarcinoma. Pancreas 39:8, pages 1254-1262.
Crossref
Crossref
Claudia Chiodoni, Mario P. Colombo & Sabina Sangaletti. (2010) Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis. Cancer and Metastasis Reviews 29:2, pages 295-307.
Crossref
Crossref
D. Capper, M. Mittelbronn, B. Goeppert, R. Meyermann & J. Schittenhelm. (2010) Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival. Neuropathology and Applied Neurobiology 36:3, pages 183-197.
Crossref
Crossref
Alexandre Chlenski & Susan L. Cohn. (2010) Modulation of matrix remodeling by SPARC in neoplastic progression. Seminars in Cell & Developmental Biology 21:1, pages 55-65.
Crossref
Crossref
Shanna A. Arnold & Rolf A. Brekken. (2009) SPARC: a matricellular regulator of tumorigenesis. Journal of Cell Communication and Signaling 3:3-4, pages 255-273.
Crossref
Crossref
Atsushi Masamune, Takashi Watanabe, Kazuhiro Kikuta & Tooru Shimosegawa. (2009) Roles of Pancreatic Stellate Cells in Pancreatic Inflammation and Fibrosis. Clinical Gastroenterology and Hepatology 7:11, pages S48-S54.
Crossref
Crossref
Raymond C. Wadlow, Ben S. Wittner, S. Aidan Finley, Henry Bergquist, Rabi Upadhyay, Stephen Finn, Massimo Loda, Umar Mahmood & Sridhar Ramaswamy. (2009) Systems-Level Modeling of Cancer-Fibroblast Interaction. PLoS ONE 4:9, pages e6888.
Crossref
Crossref
T. Reding, U. Wagner, A. B. Silva, L-K. Sun, M. Bain, S.-Y. Kim, D. Bimmler & R. Graf. (2009) Inflammation-dependent expression of SPARC during development of chronic pancreatitis in WBN/Kob rats and a microarray gene expression analysis. Physiological Genomics 38:2, pages 196-204.
Crossref
Crossref